---
$id: https://graph.org.ai/products/commodity/51111746
$type: Product
source: UNSPSC
code: "51111746"
title: "Ipilimumab"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ipilimumab

**UNSPSC Code**: 51111746
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6472H9972N1732O2004S40, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6T8C155666, more generally known as ipilimumab. European Medicines Agency schedules ipilimumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29397. The term IPILIMUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56. Most nations schedule Ipilimumab under HS 30021020 and SITC 54163. SMILES:. As of Q4 2014, IPILIMUMAB remains the US FDA Preferred Term for this commodity. . Ipilimumab bears US NLM identifiers UMLS ID C1367202 and NCI Concept Code C2654.

